Echo® MS+ system

In this application note, SCIEX demonstrates how the SCIEX Echo(R) MS System promises to provide quantitative ESI MS/MS analysis at the speed of a plate reader and with the specificity, linearity and dynamic range of a mass spectrometer.

In this application note, SCIEX discusses how the Echo MS System can be used for routine, early-stage bioanalytical quantification. This application note describes three plasma sample preparation techniques and shows how a simple sample preparation, combined with the speed and simplicity of analysis using the Echo MS System, offers an ideal approach for high-turnaround bioanalytical laboratories.

In this application note, SCIEX discusses how the Echo MS System is capable of rapidly producing high-quality results for the analysis of target peptides in minimally prepared, common fermentation broth matrix. The rapid analysis time of this platform promises faster generation of quantitative data to assess microbe strain efficiency, allowing for more rapid strain selection and removing a costly bottleneck in the important and growing field of synthetic biology.

June 26, 2025 – 16:00 BST / 17:00 CEST / 11:00 EDT / 08:00 PDT

Mass spectrometry coupled with liquid chromatography (LC-MS/MS) has become a cornerstone of clinical research for the analysis of biomarkers indicative of disease. The integration of this technology across omics applications provides significant advantages in terms of assay sensitivity, specificity, robustness, and multiplexing. These benefits are enabling researchers to gain new insights into disease etiology and pathogenesis through the identification and quantitation of disease-specific biomarkers.

In this webinar, Professor Martin Giera, Leiden University Medical Center and Professor Antonin Lamazière, Sorbonne University and Saint Antoine’s Hospital, will demonstrate how the latest advancements in mass spectrometry-based omics are providing a comprehensive assessment of disease mechanisms and patient-specific treatment responses.

The presentations will showcase several examples of how the integration of LC-MS/MS technology across various omics applications provides disease state evaluation and monitoring, ultimately resulting in more personalized and effective patient care.

Key learning objectives

• Learn best practices for the development and implementation of LC-MS/MS assays for biomarker identification and quantitation
• Discover novel, LC-MS/MS-based metabolomic and lipidomic workflows that provide semiologic indications and understanding of disease pathogenesis
• Explore recent technological advancements in LC-MS/MS hardware and bioinformatics improving performance for biomarker discovery and quantitation
• Understand the benefits of sensitive MS techniques to establish mapping of changes in the human lipidome and metabolome linked to disease onset and progression 

Who should attend?
Anyone in a clinical laboratory interested in the development of LC-MS/MS-based clinical research, biomarker discovery, and assay development. Clinical researchers, healthcare professionals, biomarker discovery experts, laboratory directors, scientists, method/assay developers, and laboratory personnels who wish to learn about best practices for assay development and LC-MS/MS methods to accurately and reliability characterize, identify, and quantify biomarkers in clinical samples.

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.

Redefine your definition of high-throughput, quantitative mass spectrometry with the Echo® MS System from SCIEX.

In this video, Chang Liu, Associate Staff Research Scientist at SCIEX, presents results from the newly designed mass spectrometry (MS) platform with integrated acoustic droplet ejection (ADE) technology. Combining pioneering innovations of an open port interface (OPI) and acoustic droplet ejection (ADE), the acoustic ejection mass spectrometry (AEMS) technology is shown to almost eliminate the laborious sample preparation required for both clean and dirty matrices such as plasma and urine, and provide second-per-sample analysis speed with high sensitivity, high reproducibility, and broad compound coverage.

In this SelectScience interview, explore key challenges, analytical solutions and future directions in cell line development

The Echo MS+ system unlocks enhanced high-throughput screening capability

New icIEF technology provides a unique and powerful analysis method to address key analytical challenges

Explore exclusive interviews, methods, and free downloads to help you optimize your mass spectrometry experiments

Built on usability, efficiency and integrity, SCIEX OS Software promises to power up the latest innovations in mass spectrometry

The latest news and technological advancements from this year’s American Society for Mass Spectrometry conference

Echo MS System delivers ultra-high throughput screening of up to 3 samples per second